Hi the following answer is another student DQ post to wish i have to reply. Please be careful with the similarity ( less than 20 %) the professor is very strict with this.
Congestive Heart Failure
Diuretics play a prominent role in managing excessive fluids among patients suffering from chronic kidney and heart failure illnesses. However, their application can result in various adverse nephric and cardiac outcomes. This discussion focuses on determining factors that are necessary for the aged diuretic therapy on the CDK and CHF victims, the prescription processes, and how kidney illnesses impact CHF treatment as well as the medication to be provided.
The first factor when selecting a specific diuretic therapy is considering the acting nature of the diuretic. Great diuretics doubles the preventive control strength while the short-term ones last for a shorter period. For instance, the prolonged nature of chlorthalidone increases the prevention of hypertension and hypokalemia. The other important factor is checking on the disease severity. Patients experiencing severe conditions should be offered a loop or collaborated diuretics (Udani & Koyner, 2016).
The medical practitioner must give out clear guidelines on how the diuretics would prevent or manage the conditions. For instance, in the first factor, the practitioner should explain to the patient the strengths and the duration of the recommended diuretic takes to control the condition. While, in the latter, the practitioner should make the patient understand how the recommended cure inhibits the receptor inhibitors (Udani & Koyner, 2016).
Renal insufficiency leads to unfavorable cardiovascular results. Patients undergoing CHF medication may experience an extended treatment duration if affected by this disorder. This is because the disease causes fractures on the left ventricles and lowers the levels of serum creatine. In combating this condition, clinicians should adopt treatment mechanisms that aim at regulating the fluid overload by using diuretics such as, angiotensin which converts the enzyme inhibitors and carrying out dialysis to prevent the condition (Sarnak, 2017).
Sarnak, M. J. (2017). A patient with heart failure and worsening kidney function. CJASN, 9(10), 1790-1798. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186522/
Udani, S. M., & Koyner, J. L. (2016). The effects of heart failure on renal function. HHS Public Access, 28(3), 453-465. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904358/